Back

Implantable cardioverter defibrillator for primary prevention in arrhythmic mitral valve prolapse: a shocking choice?

8 April 2024 (10:48 - 10:57)
Organised by: Logo
Congress Presentation Part of: Sudden cardiac death scenarios Clinical EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Raimondo Pittorru

Hospital Clinic, University of Barcelona, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
Implantable cardioverter-defibrillator implantation in incidental Brugada Syndrome diagnosed after treatment with sodium channel-blocker
Doctor S. Jacinto (Lisbon, PT)
Slides Video
Presentation thumbnail
Complex management of acute myocardial infarction in a high-risk brazilian traveler: utilizing a wearable cardioverter defibrillator for long-haul flight safety
Doctor V. Buia (Fuerth, DE)
Slides Video
Presentation thumbnail
A tale of two sisters with long QT syndrome
Doctor M. Mohamed (Coventry, GB)
Slides Video
Presentation thumbnail
A young woman with aborted sudden cardiac death and refractory vasospastic angina
Doctor A. Bozorgi (Tehran, IR)
Slides Video

Access the full session

Session thumbnail
Sudden cardiac death scenarios

The Event

Event poster

EHRA 2024

8 April 2024 10:48 CET
You may be interested in
thumbnail
Congress Presentation
Imaging the hidden risk: a multimodality approach in arrhythmic mitral valve prolapse
thumbnail
Congress Presentation
Risk stratification of patient with palpitations and arrhythmic mitral valve prolapse: ICD, ablation,or frequent monitoring?
thumbnail
Congress Presentation
The silent menace: the arrhythmogenic mitral valve prolapse as an underrecognized cause of sudden cardiac death in the young

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources